Text-Only | Login

Navigation: Home

Navigation: About

Navigation: Topics

Navigation: Projects

Navigation: Membership

Navigation: Boards

Navigation: Events

Navigation: Reports
Search.
Return to top.




Return to top.


Contact Information.


Institute of Medicine
500 Fifth Street NW
Washington DC 20001
iomwww@nas.edu
tel: 202.334.2352
fax: 202.334.1412

Media Contact
(Journalists Only)
news@nas.edu
tel. 202.334.2138
fax: 202.334.2158

Staff Directory


Return to top.

Institute of Medicine.


Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute And The Food and Drug Administration

Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute And The Food and Drug Administration


Released On:   
 March 30, 2005

Read and Purchase

Print   Email

This is an authored background paper prepared for the National Cancer Policy Board that describes the roles of two important federal agencies in cancer drug development. It does not have any recommendations or findings.  This background paper is a primer for those interested in the activities of the National Cancer Institute and the Federal Drug Administration.


Related Reports
Making Better Drugs for Children with Cancer Making Better Drugs for Children with Cancer
Apr 18, 2005


Last Updated: 6/28/2005, 05:22 PM RSS





Home | About | Topics | Projects| Memberships| Boards | Events | Reports | Sitemap
The logo of the National Acadamies. This link goes to www.nationalacademies.org.
Return to top.

Copyright © 2008 National Academy of Sciences. All rights reserved.

Terms of Use and Privacy Statement